Table 2.
Univariable and multivariable logistic regression analysis for ABMR/MVI development according to HLA and non-HLA antibodies before transplantation.
| OR | p-Value | CI (95%) | |
|---|---|---|---|
| Univariable | |||
| Recipient sex (female) | 2.932 | 0.006 | 1.372–6.265 |
| Recipient age (years) | 0.993 | 0.634 | 0.966–1.021 |
| Body mass index (kg/m2) | 1.005 | 0.873 | 0.942–1.072 |
| Cause of end-stage renal disease (immune mediated) | 0.917 | 0.860 | 0.352–2.392 |
| Preemptive KT | 1.503 | 0.463 | 0.506–4.464 |
| Median time on dialysis (months) | 1.003 | 0.703 | 0.987–1.019 |
| Donor age (years) | 0.992 | 0.565 | 0.967–1.018 |
| Donor type (live donor) | 1.024 | 0.958 | 0.420–2.500 |
| Median cold ischemia time (h) | 1.016 | 0.591 | 0.959–1.076 |
| Previous transplantation | 3.186 | 0.078 | 0.878–11.563 |
| HLA cPRA over 50% before KT | 3.827 | 0.009 | 1.396–10.492 |
| Non-HLA MFI ratio sum before KT | 1.040 | 0.010 | 1.010–1.072 |
| Multivariable | |||
| HLA cPRA over 50% before KT | 2.369 | 0.183 | 0.666–8.424 |
| Non-HLA MFI ratio sum before KT | 1.039 | 0.014 | 1.008–1.072 |
| Recipient sex (female) | 2.011 | 0.104 | 0.867–4.665 |
| Previous transplantation | 1.738 | 0.503 | 0.345–8.765 |